Quetiapine safety in older adults?

Posted on January 31, 2016 by Maurice Preter MD

Quetiapine safety in older adults? Journal of Clinical Pharmacy and Therapeutics Volume 41,  Issue 1, pages 7–18, February 2016 http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12357/abstract Abstract WHAT IS KNOWN AND OBJECTIVE: Quetiapine is a second-generation antipsychotic that is commonly prescribed for a range of approved and off-label indications … Continue reading →

Posted in Aging, development, Fifth Avenue Concierge Medicine, Health, keto, News, Psychiatry/Neurology | Tagged , , , , , , , , |

Stress resilience and subsequent risk of type 2 diabetes in 1.5 million young men

Posted on January 15, 2016 by Maurice Preter MD

    http://link.springer.com/article/10.1007/s00125-015-3846-7 Stress resilience and subsequent risk of type 2 diabetes in 1.5 million young men Casey Crump  , Jan Sundquist , Marilyn A. Winkleby , Kristina Sundquist $39.95 / €34.95 / £29.95 * * Final gross prices may vary according to local VAT. Get Access Abstract … Continue reading →

Posted in Aging, dietary, epigenetics, Events, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged , , , , , , , , |

Meta-analyses with industry involvement are massively published and report no caveats for antidepressants.

Posted on November 26, 2015 by Maurice Preter MD

CONCLUSION:

There is a massive production of meta-analyses of antidepressants for depression authored by or linked to the industry, and they almost never report any caveats about antidepressants in their abstracts. Our findings add a note of caution for meta-analyses with ties to the manufacturers of the assessed products. Continue reading →

Posted in Aging, Events, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged , , , , , |

Serotonin and the marketing of a depression myth

Posted on October 10, 2015 by Maurice Preter MD

Serotonin and the marketing of a depression myth Serotonin and depression BMJ 2015; 350 doi: http://dx.doi.org.ezproxy.cul.columbia.edu/10.1136/bmj.h1771 (Published 21 April 2015)Cite this as: BMJ 2015;350:h1771  Article Related content Metrics Responses David Healy, professor of psychiatry Author affiliations david.healy54@googlemail.com The marketing of a myth The serotonin reuptake inhibiting … Continue reading →

Posted in Aging, China, dietary, epigenetics, Events, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged , , , , |

Benzodiazepine use and risk of Alzheimer’s disease

Posted on October 10, 2015 by Maurice Preter MD

Benzodiazepine use is associated with an increased risk of Alzheimer’s disease. The stronger association observed for long term exposures reinforces the suspicion of a possible direct association, even if benzodiazepine use might also be an early marker of a condition associated with an increased risk of dementia. Unwarranted long term use of these drugs should be considered as a public health concern. Continue reading →

Posted in Aging, China, Events, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged , , , , , |